169 related articles for article (PubMed ID: 18539029)
1. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
Oberg CT; Blanchard H; Leffler H; Nilsson UJ
Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions.
Sörme P; Kahl-Knutsson B; Huflejt M; Nilsson UJ; Leffler H
Anal Biochem; 2004 Nov; 334(1):36-47. PubMed ID: 15464951
[TBL] [Abstract][Full Text] [Related]
3. Taloside inhibitors of galectin-1 and galectin-3.
Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H
Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701
[TBL] [Abstract][Full Text] [Related]
4. An integrated computational analysis of the structure, dynamics, and ligand binding interactions of the human galectin network.
Guardia CM; Gauto DF; Di Lella S; Rabinovich GA; Martí MA; Estrin DA
J Chem Inf Model; 2011 Aug; 51(8):1918-30. PubMed ID: 21702482
[TBL] [Abstract][Full Text] [Related]
5. Quaternary solution structures of galectins-1, -3, and -7.
Morris S; Ahmad N; André S; Kaltner H; Gabius HJ; Brenowitz M; Brewer F
Glycobiology; 2004 Mar; 14(3):293-300. PubMed ID: 14693909
[TBL] [Abstract][Full Text] [Related]
6. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
7. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and galectin-binding activities of mercaptododecyl glycosides containing a terminal β-galactosyl group.
Murakami T; Yoshioka K; Sato Y; Tanaka M; Niwa O; Yabuki S
Bioorg Med Chem Lett; 2011 Feb; 21(4):1265-9. PubMed ID: 21237642
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
[TBL] [Abstract][Full Text] [Related]
11. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
12. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
[TBL] [Abstract][Full Text] [Related]
13. Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.
van Hattum H; Branderhorst HM; Moret EE; Nilsson UJ; Leffler H; Pieters RJ
J Med Chem; 2013 Feb; 56(3):1350-4. PubMed ID: 23281927
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
[TBL] [Abstract][Full Text] [Related]
15. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
[TBL] [Abstract][Full Text] [Related]
16. Arene-anion based arginine-binding motif on a galactose scaffold: structure-activity relationships of interactions with arginine-rich galectins.
Öberg CT; Noresson AL; Leffler H; Nilsson UJ
Chemistry; 2011 Jul; 17(29):8139-44. PubMed ID: 21656580
[TBL] [Abstract][Full Text] [Related]
17. Structure of the mouse galectin-4 N-terminal carbohydrate-recognition domain reveals the mechanism of oligosaccharide recognition.
Krejčiříková V; Pachl P; Fábry M; Malý P; Rezáčová P; Brynda J
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):204-11. PubMed ID: 21358051
[TBL] [Abstract][Full Text] [Related]
18. Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals.
van Klaveren S; Sundin AP; Jakopin Ž; Anderluh M; Leffler H; Nilsson UJ; Tomašič T
ChemMedChem; 2022 Mar; 17(6):e202100575. PubMed ID: 34913595
[TBL] [Abstract][Full Text] [Related]
19. Double affinity amplification of galectin-ligand interactions through arginine-arene interactions: synthetic, thermodynamic, and computational studies with aromatic diamido thiodigalactosides.
Cumpstey I; Salomonsson E; Sundin A; Leffler H; Nilsson UJ
Chemistry; 2008; 14(14):4233-45. PubMed ID: 18366047
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8.
Bohari MH; Yu X; Kishor C; Patel B; Go RM; Eslampanah Seyedi HA; Vinik Y; Grice ID; Zick Y; Blanchard H
ChemMedChem; 2018 Aug; 13(16):1664-1672. PubMed ID: 29926535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
